Additionally, the long non-coding RNA (LncRNA) ORLNC1 can upregulate PTEN in HER2+ BC by competitively binding with miR-296, inhibiting the proliferation of these tumor cells both in vitro and in vivo [55]. This evidence concerns the gene PTEN and breast cancer.